BRH.L

Braveheart Investment Group Plc
Braveheart Inv Group - Investment in IQ-AI Limited and RPT
11th October 2024, 09:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 8851H
Braveheart Investment Group plc
11 October 2024
 

11 October 2024

 

Braveheart Investment Group plc

("Braveheart" or the "Company")

 

Acquisition of Interest in IQ-AI Limited

and

Related Party Transaction

 

Braveheart Investment Group (AIM: BRH), announces the acquisition of 65,415,862 ordinary shares of 0.1 pence each in IQ-AI Limited ("IQ-AI"), representing 29.51% of the issued share capital of IQ-AI, for a total consideration of £719,574.48.

 

45,761,083 shares in IQ-AI have been purchased from Trevor Brown, CEO of Braveheart, at a price of 1.1 pence per share, for a consideration of £503,371.91. A further 19,654,779 shares in IQ-AI Shares have been purchased from Free Association Books Limited ("FAB"), a company owned by the children of Trevor Brown, also at a price of 1.1p per IQ-AI share for a consideration of £216,202.57.

 

IQ-AI is an imaging software and healthcare diagnostics company, whose subsidiaries include Imaging Biometrics, LLC ("IB") and Stone Checker Software Limited. IB is a healthcare imaging software company that supplies medical technology solutions, regulatory consulting services and has a neuroimaging product portfolio. Stone Checker Software Limited is a supplier of technology solutions in the field of kidney stone analysis and kidney stone prevention. IQ-AI's ordinary shares are listed on the main market of the London Stock Exchange. Trevor Brown is the CEO of IQ-AI.

 

In the year ended 31 December 2023, IQ-AI made a loss before tax of approximately £0.62 million on revenue of approximately £0.6 million and as at that date had net assets of approximately £0.09 million. As at 30 June 2024, IQ-AI had net assets of approximately £0.43 million.

 

The independent directors of Braveheart were offered an opportunity to acquire a substantial stake in IQ-AI. They considered that IB is making progress in its Phase 1 Clinical Trial of gallium maltolate, as reported by IQ-AI on 13 August 2024. The IQ-AI business fits well with Braveheart's investment strategy and will make an attractive addition to Braveheart's investment portfolio at what the board considered is an attractive entry price.

 

 

Related Party Transaction

 

Trevor Brown and FAB are deemed to be related parties under the AIM Rules for Companies. The independent directors, being Qu Li, Susan Hagan and Vivian Hallam, consider, having consulted with Allenby Capital Limited, the Company's Nominated Adviser, that the terms of the purchase of the IQ-AI shares is fair and reasonable insofar as the shareholders of Braveheart are concerned.

 

For further information:

 

Braveheart Investment Group plc

Tel: 01738 587555

Trevor Brown CEO




Allenby Capital Limited (Nominated Adviser and Joint Broker)

Tel: 020 3328 5656

James Reeve / George Payne




Peterhouse Capital Limited (Joint Broker)

Tel: 020 7469 0936

Duncan Vasey / Lucy Williams


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQVFLBFZBLEFBQ]]>
TwitterFacebookLinkedIn